SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016)
-
M. Muñoz [1] ; A. Santaballa [9] ; M. A. Seguí [2] ; C. Beato [3] ; S. de la Cruz [4] ; J. Espinosa [5] ; P. J. Fonseca [6] ; J. Perez [7] ; T. Quintanar [7] ; A. Blasco [8]
-
[1] Hospital Clinic Barcelona
Hospital Clinic Barcelona
Barcelona, España
-
[2] Corporació Sanitària Parc Taulí
Corporació Sanitària Parc Taulí
Barcelona, España
-
[3] Hospital Universitario Virgen Macarena
Hospital Universitario Virgen Macarena
Sevilla, España
-
[4] Gobierno de Navarra
Gobierno de Navarra
Pamplona, España
-
[5] Hospital General de Ciudad Real
Hospital General de Ciudad Real
Ciudad Real, España
-
[6] Hospital Universitario Central de Asturias
Hospital Universitario Central de Asturias
Oviedo, España
-
[7] Hospital General Universitario de Elche
Hospital General Universitario de Elche
Elche, España
-
[8] Hospital General Universitario de Valencia
Hospital General Universitario de Valencia
Valencia, España
-
[9] Hospital Universitari I Politècnic la Fe, España
-
- Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 18, Nº. 12 (December 2016), 2016, págs. 1229-1236
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
Chemotherapy and radiotherapy often result in reduced fertility in cancer patients. With increasing survival rates, fertility is an important quality-of-life concern for many young cancer patients. Around 70–75% of young cancer survivors are interested in parenthood but the numbers of patients who access fertility preservation techniques prior to treatment are significantly lower. Moreover, despite existing guidelines, healthcare professionals do not address fertility preservation issues adequately. There is a critical need for improvements in clinical care to ensure patients are well informed about infertility risks and fertility preservation options and to support them in their reproductive decision-making prior to cancer treatment.
